Cargando…
Cross-Platform Synaptic Network Analysis of Human Entorhinal Cortex Identifies TWF2 as a Modulator of Dendritic Spine Length
Proteomic studies using postmortem human brain tissue samples have yielded robust assessments of the aging and neurodegenerative disease(s) proteomes. While these analyses provide lists of molecular alterations in human conditions, like Alzheimer's disease (AD), identifying individual proteins...
Autores principales: | Walker, Courtney K., Greathouse, Kelsey M., Tuscher, Jennifer J., Dammer, Eric B., Weber, Audrey J., Liu, Evan, Curtis, Kendall A., Boros, Benjamin D., Freeman, Cameron D., Seo, Jung Vin, Ramdas, Raksha, Hurst, Cheyenne, Duong, Duc M., Gearing, Marla, Murchison, Charles F., Day, Jeremy J., Seyfried, Nicholas T., Herskowitz, Jeremy H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Neuroscience
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198456/ https://www.ncbi.nlm.nih.gov/pubmed/37055180 http://dx.doi.org/10.1523/JNEUROSCI.2102-22.2023 |
Ejemplares similares
-
Integrated Proteomics to Understand the Role of Neuritin (NRN1) as a Mediator of Cognitive Resilience to Alzheimer’s Disease
por: Hurst, Cheyenne, et al.
Publicado: (2023) -
Distinct roles of Bdnf I and Bdnf IV transcript variant expression in hippocampal neurons
por: Bach, Svitlana V., et al.
Publicado: (2023) -
Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease
por: Higginbotham, Lenora, et al.
Publicado: (2020) -
A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain
por: Umoh, Mfon E, et al.
Publicado: (2017) -
Effects of APOE Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease
por: Dai, Jingting, et al.
Publicado: (2018)